Rheumocam 15 mg/mL oral suspension for cattle (Canada)

Company: Merck Animal Health

Meloxicam Oral Suspension, Mfr. Std

DIN 02497263

Veterinary Use Only

Nonsteroidal anti-inflammatory drug (NSAID) for cattle.

Active Ingredients

Each mL contains 15 mg meloxicam as active ingredient and 5 mg sodium benzoate as preservative.

Rheumocam 15 mg/mL oral suspension for cattle Indications

For alleviation of pain and inflammation following surgical and band castration in cattle.

Dosage and Administration

Shake the content well before use. Single oral administration of 1.0 mg meloxicam/kg body weight (10 mL/150 kg) should be administered approximately 1-2 hours prior to castration procedure. Using a dosing syringe, ensure the entire dose is administered at the back of the tongue to avoid spillage.

Contraindications

Do not use in animals with gastrointestinal disorders such as irritation and hemorrhage, impaired hepatic, cardiac or renal function and hemorrhagic disorders or where there is individual hypersensitivity to the product.

Do not administer concurrently with steroidal, other nonsteroidal anti-inflammatory drugs or with anti-coagulant agents.

Cautions: Avoid use in very severely dehydrated, hypovolemic or hypotensive animals which require parenteral rehydration, as there may be a potential risk of increased renal toxicity.

Use of anti-inflammatories in very young or debilitated animals may involve additional risk.

Treatment of calves with meloxicam before castration reduces post-operative pain. An anti-inflammatory alone will not provide adequate pain relief during the castration procedure. To obtain adequate pain relief during surgery co-medication with an appropriate analgesic is recommended. Concomitant use of NSAID’s with aminoglycoside antimicrobials in very young animals may result in renal toxicity.

Warnings

Keep out of reach of children.

Treated animals must not be used in food for at least 35 days after the latest treatment with this drug.

Do not use in lactating dairy cattle.

Do not use in calves to be processed for veal as a withdrawal period has not been established for pre-ruminating calves.

Adverse Reactions

If you notice any adverse events please report them to the manufacturer or your veterinarian.

Pharmacology

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic and anti-pyretic properties. Plasma levels of meloxicam reached therapeutic values approximately two hour post administration. Therapeutic levels were seen for approximately 56 hours post dosing.

Storage

Store at 15-30°C. Once opened use within 3 months.

Presentation: 100 mL, 150 mL, 250 mL, 1 L and 5 L plastic bottles.

Manufactured by:

Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway, Ireland

Imported by:

Intervet Canada Corp., subsidiary of Merck & Co., Inc., 16750, route Transcanadienne, Kirkland, QC H9H 4M7

1 866 683-7838

Date: July 2^nd, 2020

20-0008INS

LA20746

CPN: 1208329.1